April 16, 2026

Panic for patients across the nation as the Food and Drug Administration announces a recall of Xanax, hitting a single lot, 8177156, of 3 mg tablets packed 60 to a bottle and set to expire on 02/28/2027. The pills, distributed by Viatris Specialty of Morgantown, West Virginia and made in Ireland, were pulled after failing dissolution specifications, with the affected product bearing NDC number 58151-506-91. According to the California State Board of Pharmacy, the medication was shipped in the U.S. from Aug. 27, 2024 through May 29, 2025. The recall was first announced on March 17 and later escalated to a Class II on April 8, sending a jolt through the supply chain and leaving patients and pharmacies on alert.

FDA recalls Xanax for not dissolving—apparently even the pills are too anxious to commit.

Leave a Reply